Corrigendum to "Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease" [NeuroToxicology 90 (2022) 19-34].

Kumar, R; Kumar, R; Sharma, N; Khurana, N; Singh, SK; Satija, S; Mehta, M; Vyas, M

Corrigendum to "Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease" [NeuroToxicology 90 (2022) 19-34].

Kumar, R Kumar, R Sharma, N Khurana, N Singh, SK Satija, S

Mehta, M Vyas, M

Permalink

Publisher:: ELSEVIER
Publication Type:: Journal Article
Citation:: Neurotoxicology, 2023, 99, pp. 332
Issue Date:: 2023-12

Closed Access

	Filename	Description	Size
	1-s2.0-S0161813X23001092-main.pdf	Published version	222.6 kB		View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Kumar, R
dc.contributor.author	Kumar, R
dc.contributor.author	Sharma, N
dc.contributor.author	Khurana, N
dc.contributor.author	Singh, SK
dc.contributor.author	Satija, S https://orcid.org/0000-0003-4702-6534
dc.contributor.author	Mehta, M
dc.contributor.author	Vyas, M
dc.date.accessioned	2024-02-12T23:49:20Z
dc.date.available	2024-02-12T23:49:20Z
dc.date.issued	2023-12
dc.identifier.citation	Neurotoxicology, 2023, 99, pp. 332
dc.identifier.issn	0161-813X
dc.identifier.issn	1872-9711
dc.identifier.uri	http://hdl.handle.net/10453/175611
dc.description.abstract	The authors wish to clarify that the data represented in this article for comparator groups; control, model (M), model + donepezil (M + Dnpz), were shared with another study Kumar et al., 2021 as per the approved protocol due to the animal ethics constraints. DOI of original article: https://doi.org/10.1016/j.neuro.2022.02.009.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	ELSEVIER
dc.relation.ispartof	Neurotoxicology
dc.relation.isbasedon	10.1016/j.neuro.2023.09.002
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1109 Neurosciences, 1115 Pharmacology and Pharmaceutical Sciences
dc.subject.classification	Toxicology
dc.subject.classification	3209 Neurosciences
dc.subject.classification	3214 Pharmacology and pharmaceutical sciences
dc.title	Corrigendum to "Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease" [NeuroToxicology 90 (2022) 19-34].
dc.type	Journal Article
utslib.citation.volume	99
utslib.location.activity	Netherlands
utslib.for	1109 Neurosciences
utslib.for	1115 Pharmacology and Pharmaceutical Sciences
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Engineering and Information Technology
pubs.organisational-group	University of Technology Sydney/Faculty of Health
pubs.organisational-group	University of Technology Sydney/Faculty of Science
pubs.organisational-group	University of Technology Sydney/Faculty of Health/Public Health
utslib.copyright.status	closed_access	*
dc.date.updated	2024-02-12T23:49:19Z
pubs.publication-status	Published
pubs.volume	99

Abstract:

The authors wish to clarify that the data represented in this article for comparator groups; control, model (M), model + donepezil (M + Dnpz), were shared with another study Kumar et al., 2021 as per the approved protocol due to the animal ethics constraints. DOI of original article: https://doi.org/10.1016/j.neuro.2022.02.009.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/175611